Vascular Web Logo

SVS  SVS Foundation
A A A
VascularWeb

 PS80. Stent Migration: A Risk in the Treatment of Renal Access Patients

Andrew J. Olinde1, Devin Conway1, Jay Hollman1, John Schellack2, Paul Perkowski2, Joseph Griffin1
1Vascular Specialty Center, Baton Rouge, LA; 2Vascular Clinic, Baton Rouge, LA.


OBJECTIVES: Central venous strictures often lead to significant arm swelling and access malformation in patients with chronic renal failure. The purpose of this study is to acknowledge the risk of stent migration in this subset of patients treated for failing access grafts.

METHODS: A retrospective chart review of patients undergoing diagnostic fistulagrams and percutaenous intervention of malfunctioning accesses was done from June 2007 to November 2012 in 2 major hospitals in Baton Rouge, Louisiana. A total of 5,184 fistulagrams were performed. 1,189 (22.9%) procedures involved percutaneous thrombectomy of the accesses. 2,882 (55.6%) procedures included balloon dilatation of the access or venous outflow strictures. Seven hundred ninety-six (15.3%) patients had stents placed either in the access or proximal central veins.

RESULTS: Of the 796 stents placed in this series, 6 migrated after deployment over varied time periods. Five stents migrated to the heart requiring open heart surgical removal. One patient had a stent migrate from the right subclavian vein to the innominate vein.

CONCLUSIONS: Migration of stents can occur in the treatment of failing renal access grafts. This is the largest reported series to date in the literature of such events in renal failure patients. The majority of stents migrated to the heart. The high-flow system generated by these renal access grafts and eventual gradual central vein dilatation in this patient population increase the risk of future migration. Interventionalists must be cognizant of this potential complication with the need for selective accurate placement of stents. Despite proper placement, stent migration may be unavoidable.

AUTHOR DISCLOSURES: D. Conway: Nothing to disclose; J. Griffin: Nothing to disclose; J. Hollman: Nothing to disclose; A. J. Olinde: Nothing to disclose; P. Perkowski: Nothing to disclose; J. Schellack: Nothing to disclose.
Patients
1
2
3
4
5
BM-Bare Metal CS-Covered
10mm X 26mm BM
7mm X 40mm CS
9mm X 40mm BM
10mm X 60mm BM 12mm X 60 mm BM
11mm X 100mm CS
Location Placed
subclavian vein
proximal access graft
basilic vein
common and external iliac veins
subclavian vein
Migration Diagnosed
4 days
same day
3 years
6 weeks
8 months
Migration Destination
tricuspid valve
pulmonary valve
tricuspid valve
right atrium and right ventricle
innominate vein
Treatment
open heart retrieval
open heart retrieval
postmortem retrieval
open heart retrieval
balloon dilatation of stent
 

 

 

Posted April 2013

Contact Us

Society for Vascular Surgery
633 North Saint Clair Street, 22nd Floor | Chicago, IL 60611
Phone: 312-334-2300 | 800-258-7188
Fax: 312-334-2320
Email: vascular@vascularsociety.org

Follow Us

YouTube

VascularWeb® is the prime source for all vascular health and disease information, and is presented by the Society for Vascular Surgery®. Its members are vascular surgeons, specialists, and vascular health professionals who are specialty-trained in all treatments for vascular disease including medical management, non-invasive procedures, and surgery.